文献速递妇科

上皮性卵巢癌肿瘤间共享癌-睾丸抗原表达

Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors.
PubMed 文献 · Gynecol Oncol · 2017-04-06

研究评估62例上皮性卵巢癌标本、8个卵巢癌细胞系和3份良性卵巢组织中20种癌-睾丸抗原的表达,95%的肿瘤表达至少一种抗原,MAGE A4最常见(65%),肿瘤间共享抗原的程度随表达抗原总数增加而增加。

要点

  • 95%的上皮性卵巢癌标本表达至少一种癌-睾丸抗原,但无单一抗原在所有样本中普遍表达。
  • 最常表达的癌-睾丸抗原为MAGE A4(65%),平均表达抗原数为4.5种(范围0-17)。
  • 肿瘤间共享抗原的程度随表达抗原总数增加而增加,提示多表位免疫治疗策略。

核心结论

  • 癌-睾丸抗原在上皮性卵巢癌标本中表达率为95%,但无单一抗原在所有样本中普遍表达,肿瘤间共享抗原程度随表达抗原总数增加,提示多表位方法开发卵巢癌免疫治疗。

研究设计与样本

  • 从上皮性卵巢癌肿瘤标本、上皮性卵巢癌细胞系和良性卵巢组织标本中分离RNA,用实时PCR分析20种癌-睾丸抗原的表达水平。
  • 共评估62例上皮性卵巢癌标本、8个卵巢癌细胞系和3份良性卵巢组织;大多数标本为高级别(62%)、浆液性(68%)和晚期(74%)。

主要发现

  • 58例(95%)上皮性卵巢癌肿瘤表达至少一种评估的癌-睾丸抗原,平均表达抗原数为4.5种(范围0-17)。
  • 最常表达的癌-睾丸抗原为MAGE A4(65%)。
  • 抗原共享分析显示:9例肿瘤仅共享一种抗原,占评估标本的62%;37例肿瘤共享4种或以上抗原,占82%;5例肿瘤表达超过10种癌-睾丸抗原,与90%的肿瘤面板共享。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cancer-testis (CT) antigens have been proposed as potential targets for cancer immunotherapy. Our objective was to evaluate the expression of a panel of CT antigens in epithelial ovarian cancer (EOC) tumor specimens, and to determine if antigen sharing occurs between tumors. METHODS: RNA was isolated from EOC tumor specimens, EOC cell lines and benign ovarian tissue specimens. Real time-PCR analysis was performed to determine the expression level of 20 CT antigens. RESULTS: A total of 62 EOC specimens, 8 ovarian cancer cell lines and 3 benign ovarian tissues were evaluated for CT antigen expression. The majority of the specimens were: high grade (62%), serous (68%) and advanced stage (74%). 58 (95%) of the EOC tumors analyzed expressed at least one of the CT antigens evaluated. The mean number of CT antigen expressed was 4.5 (0-17). The most frequently expressed CT antigen was MAGE A4 (65%). Antigen sharing analysis showed the following: 9 tumors shared only one antigen with 62% of the evaluated specimens, while 37 tumors shared 4 or more antigens with 82%. 5 tumors expressed over 10 CT antigens, which were shared with 90% of the tumor panel. CONCLUSION: CT antigens are expressed in 95% of EOC tumor specimens. However, not a single antigen was universally expressed across all samples. The degree of antigen sharing between tumors increased with the total number of antigens expressed. These data suggest a multi-epitope approach for development of immunotherapy for ovarian cancer treatment.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Garcia-Soto AE, Schreiber T, Strbo N, et al. Cancer-testis antigen expression is shared between epithelial ovarian cancer tumors. Gynecol Oncol. 2017. PMID: 28392126. doi:10.1016/j.ygyno.2017.03.512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。